Will Next Month Produce Gains For These Marijuana Stocks The month of…

The post Two Marijuana Stocks To Watch Heading Into July  appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
How hemp, cannabis growers use technology, automation to cut costs amid pandemic
(A version of this story originally appeared on Marijuana Business Daily.) Hemp and cannabis cultivators are turning to technology and automation to help achieve efficiencies, cut costs and keep workers safe during the coronavirus pandemic and the current economic downturn. Growers report technology and automation solutions include: Automated irrigation,... Read more
If Kentucky Rep. Charles Booker (D) wins his primary race for U.S. Senate—and initial voting returns from Tuesday’s election put him in the lead so far—the general election matchup heading up to November will see the pro-marijuana legalization candidate face off against one of the most powerful obstacles to... Read more
This is a sponsored post by Larry Sandell of Mei & Mark LLP. This post was updated on May 22, 2019 to reflect recent policy developments. Marijuana industry leaders stay busy developing business plans, building brands, inventing technologies, creating supply chains, cultivating new strains, hiring employees, securing funding, and obtaining... Read more
Even though Virginia has decriminalized cannabis as of first thing next month, the state’s Black caucus would like to see things move to full legalization. Their plan is to try and push that through in a special legislative session this summer.  “The Commonwealth is past the point for studies... Read more
Seven out of ten Americans believe that smoking marijuana is morally acceptable, according to a poll that tracks values and beliefs in the United States. Results of the poll that surveys American’s views on the moral acceptability of 21 different social issues were released this week by Gallup. When... Read more
Regulators in the United Kingdom have rescheduled the cannabidiol drug Epidyolex as a Schedule 5 drug, moving the medicine approved to treat severe forms of epilepsy from the much more restrictive Schedule 2 classification. GW Pharmaceuticals, the manufacturer of the medication, announced on Tuesday that the move by the... Read more
Dr. Lester Grinspoon, one of the most vocal champions of marijuana legalization in the United States who promoted his advocacy in both best-selling books and Congressional testimony, died on Thursday. He was 92.  A native of Massachusetts, Grinspoon studied at Harvard Medical School, and later joined the faculty there... Read more
If Kentucky Rep. Charles Booker (D) wins his primary race for U.S. Senate—and initial voting returns from Tuesday’s election put him in the lead so far—the general election matchup heading up to November will see the pro-marijuana legalization candidate face off against one of the most powerful obstacles to... Read more

Can These Pot Stocks Show Value In The Coming Months? When we…

The post Are These Marijuana Stocks Worth The Investment? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )